Clinical trials: Bone Marrow Failure Syndrome

Aplastic Anemia

ATGAM General Investigation

• Active, not recruiting
• Age: 0 years and older
• Observational study

The objective of this study is to confirm the safety of ATGAM in patients with moderate to severe aplastic anemia under the actual use in Japan.

Trial name

NCT06039020

Testing

Anti-human thymocyte immunoglobulin, equine

Where

Japan

Volunteers

1 people

Sponsor

Pfizer